Form 4: Generation Bio Co. Executive Phillip Samayoa Reports Stock Transactions
SEC Form 4 Filing
Phillip Samayoa, Chief Scientific Officer of Generation Bio Co., reports the vesting and subsequent sale of restricted stock units.
Summary
- On January 15, 2025, Phillip Samayoa, the Chief Scientific Officer of Generation Bio Co., executed transactions involving the company's common stock.
- Samayoa vested 1,147 restricted stock units (RSUs) and sold the corresponding shares.
- Additionally, 398 shares were disposed of to cover tax obligations at a price of $0.888 per share.
- Following these transactions, Samayoa directly owns 127,709 shares of Generation Bio Co. common stock and 9,170 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of insider transactions, neither particularly positive nor negative.
Industry Context
This is a standard SEC Form 4 filing, reflecting insider transactions. Such filings are common and provide transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions have a minimal impact on stakeholders as they represent a small portion of the outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 01/20/2023 | Reporting person was granted 18,345 restricted stock units. |
| 01/15/2024 | 25% of the 18,345 restricted stock units vested. |
| 01/15/2025 | Vesting of 1,147 restricted stock units and subsequent sale; Tax obligation disposal of 398 shares. |
| 01/17/2025 | Date of form signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.